BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 15180864)

  • 1. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.
    Passweg JR; Rabusin M; Musso M; Beguin Y; Cesaro S; Ehninger G; Espigado I; Iriondo A; Jost L; Koza V; Lenhoff S; Lisukov I; Locatelli F; Marmont A; Philippe P; Pilatrino C; Quartier P; Stary J; Veys P; Vormoor J; Wahlin A; Zintl F; Bocelli-Tyndall C; Tyndall A; Gratwohl A;
    Br J Haematol; 2004 Jun; 125(6):749-55. PubMed ID: 15180864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias.
    Passweg JR; Rabusin M
    Autoimmunity; 2008 Dec; 41(8):660-5. PubMed ID: 18958755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haematopoietic stem cell transplantation for immune thrombopenia and other refractory autoimmune cytopenias.
    Passweg JR
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):305-15. PubMed ID: 15302342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease.
    Tyndall A; Fassas A; Passweg J; Ruiz de Elvira C; Attal M; Brooks P; Black C; Durez P; Finke J; Forman S; Fouillard L; Furst D; Holmes J; Joske D; Jouet J; Kötter I; Locatelli F; Prentice H; Marmont AM; McSweeney P; Musso M; Peter HH; Snowden JA; Sullivan K; Gratwohl A
    Bone Marrow Transplant; 1999 Oct; 24(7):729-34. PubMed ID: 10516675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune disease after autologous hematopoietic stem cell transplantation.
    Bohgaki T; Atsumi T; Koike T
    Autoimmun Rev; 2008 Jan; 7(3):198-203. PubMed ID: 18190878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic SCT for patients with autoimmune diseases.
    Daikeler T; Hügle T; Farge D; Andolina M; Gualandi F; Baldomero H; Bocelli-Tyndall C; Brune M; Dalle JH; Urban C; Ehninger G; Gibson B; Linder B; Lioure B; Marmont A; Matthes-Martin S; Nachbaur D; Schuetz P; Tyndall A; van Laar JM; Veys P; Saccardi R; Gratwohl A;
    Bone Marrow Transplant; 2009 Jul; 44(1):27-33. PubMed ID: 19139739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children.
    Rabusin M; Snowden JA; Veys P; Quartier P; Dalle JH; Dhooge C; Di Bartolomeo P; Gonzalez-Vicent M; Gibson B; Iriondo A; Juergens H; Lisukov I; Messina C; Mialou V; Steward CG; Urban C; Renard M; Giurici N; Peters C; Badoglio M; Ronfani L; Dini G; Farge D; Saccardi R;
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):666-9. PubMed ID: 23253561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
    Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
    Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell transplantation for severe autoimmune diseases: progress and problems.
    Marmont AM
    Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease.
    Rabusin M; Andolina M; Maximova N; Lepore L; Parco S; Tuveri G; Jankovic G
    Haematologica; 2000 Nov; 85(11 Suppl):81-5. PubMed ID: 11268330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report.
    Woessmann W; Peters C; Lenhard M; Burkhardt B; Sykora KW; Dilloo D; Kremens B; Lang P; Führer M; Kühne T; Parwaresch R; Ebell W; Reiter A
    Br J Haematol; 2006 Apr; 133(2):176-82. PubMed ID: 16611309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
    Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
    Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe Evans syndrome with an allogeneic cord blood transplant.
    Raetz E; Beatty PG; Adams RH
    Bone Marrow Transplant; 1997 Sep; 20(5):427-9. PubMed ID: 9339762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous hematopoietic stem cell transplantation for autoimmune diseases.
    Gratwohl A; Passweg J; Bocelli-Tyndall C; Fassas A; van Laar JM; Farge D; Andolina M; Arnold R; Carreras E; Finke J; Kötter I; Kozak T; Lisukov I; Löwenberg B; Marmont A; Moore J; Saccardi R; Snowden JA; van den Hoogen F; Wulffraat NM; Zhao XW; Tyndall A;
    Bone Marrow Transplant; 2005 May; 35(9):869-79. PubMed ID: 15765114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
    Nash RA
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation.
    Musso M; Porretto F; Crescimanno A; Polizzi V; Scalone R
    Bone Marrow Transplant; 2004 Apr; 33(7):769-71. PubMed ID: 14755320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
    Ganguly S; Divine CL; Deauna-Limayo D; Bodensteiner DC; Cook JD; Lewis JN; Skikne BS
    Ann Hematol; 2005 Aug; 84(8):526-31. PubMed ID: 15915350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation.
    Bielski M; Yomtovian R; Lazarus HM; Rosenthal N
    Bone Marrow Transplant; 1998 Dec; 22(11):1071-6. PubMed ID: 9877269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.